Gregory L. Verdine - 27 Oct 2022 Form 4 Insider Report for Wave Life Sciences Ltd. (WVE)

Role
Director
Signature
/s/ Gregory L. Verdine
Issuer symbol
WVE
Transactions as of
27 Oct 2022
Net transactions value
$0
Form type
4
Filing time
28 Oct 2022, 20:00:13 UTC
Previous filing
17 Aug 2022
Next filing
09 Aug 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WVE Share Option (right to buy) Award $0 +163,467 $0.000000 163,467 27 Oct 2022 Ordinary Shares 163,467 $4.37 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person was granted this option pursuant to his existing consulting agreement with Wave. The option vests in equal monthly installments beginning on October 31, 2022, through December 31, 2024, subject to the reporting person's continued services through the applicable vesting date.